Header Logo

Connection

Michael Jelinek to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Michael Jelinek has written about Carcinoma, Non-Small-Cell Lung.
Michael Jelinek
Connection Strength
0.690
Carcinoma, Non-Small-Cell Lung
  1. Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600.
    View in: PubMed
    Score: 0.536
  2. A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. J Thorac Oncol. 2022 01; 17(1):130-140.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.